- Home
- All Stock List
- NSE
- P I Industries Ltd Share Price
3,640.20
-7.50 (-0.21%)
-
Outperforms Index
-0.38%
Return (1Y)
Beaten Nifty Commodities by 2.83%
-
More Volatile
1.71%
Standard Deviation (1Y)
Higher than Nifty Commodities by 0.28%
-
Not so consistent
6/12
Months
underperformed Nifty Commodities
-
AxisDirect View
No View
4,804
2,951
News & Announcements
-
However, revenue from operations grew marginally by 0.17% YoY to Rs 1,900.8 crore in the quarter ended 31 December 2024.
Domestic revenues grew by 5% YoY, with volume up by approximately 7%. Biological products’ drove growth, with revenue increasing by 20% YoY.
Agchem exports saw a growth of approximately 2% with volume growth of 5%. The performance of new products was a key contributor, with revenue from new products growing by around 40% YoY. Pharma exports contributed approximately 4% of the overall exports.
The firm’s increase in overheads was attributed to promotion expenses for the launch of new products, as well as adding resources to build the Pharma2 business and integrate PHC.
EBITDA redused by 8% to Rs 512.2 crore in Q3 of FY25 from Rs 555 crore in the same quarter last year. EBITDA margin reduced to 27% in Q3 FY25 as against 29% recorded in Q3 FY24.
Gross margin declined to 53% in Q3 FY25, down from 54% in Q3 FY24, a reduction of approximately 85 bps YoY.
On a nine-month basis, the company’s consolidated net profit advanced 1.35% to Rs 1,329.7 crore on a 4.49% rise in revenue from operations to Rs 6,190.7 crore in 9M FY25 over 9M FY24.
PI Industries operates in the domestic agricultural inputs and custom synthesis manufacturing (CSM) exports segments. It is a leading player in the domestic agricultural inputs sector, primarily dealing in agrochemicals and plant nutrients.
Powered by Capital Market - Live News
-
P I Industries consolidated net profit declines 16.92% in the December 2024 quarter
07 - Feb - 2025 12:00 | 83 days ago
Net profit of P I Industries declined 16.92% to Rs 372.70 crore in the quarter ended December 2024 as against Rs 448.60 crore during the previous quarter ended December 2023. Sales rose 0.17% to Rs 1900.80 crore in the quarter ended December 2024 as against Rs 1897.50 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 1900.80 1897.50 0 OPM % 26.94 29.18 - PBDT 579.80 604.10 -4 PBT 480.70 525.80 -9 NP 372.70 448.60 -17 Powered by Capital Market - Live News
-
PI Industries announced that the Board of Directors of the Company at its meeting held on 6 February 2025, inter alia, have recommended the interim dividend of Rs 6 per equity Share (i.e. 600%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
-
P I Industries consolidated net profit declines 16.92% in the December 2024 quarter
07 - Feb - 2025 12:00 | 83 days ago
Net profit of P I Industries declined 16.92% to Rs 372.70 crore in the quarter ended December 2024 as against Rs 448.60 crore during the previous quarter ended December 2023. Sales rose 0.17% to Rs 1900.80 crore in the quarter ended December 2024 as against Rs 1897.50 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 1900.80 1897.50 0 OPM % 26.94 29.18 - PBDT 579.80 604.10 -4 PBT 480.70 525.80 -9 NP 372.70 448.60 -17 Powered by Capital Market - Live News
-
PI Industries announced that the Board of Directors of the Company at its meeting held on 6 February 2025, inter alia, have recommended the interim dividend of Rs 6 per equity Share (i.e. 600%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
-
PI Industries announces board meeting date
97 days ago
-
However, revenue from operations grew marginally by 0.17% YoY to Rs 1,900.8 crore in the quarter ended 31 December 2024.
Domestic revenues grew by 5% YoY, with volume up by approximately 7%. Biological products’ drove growth, with revenue increasing by 20% YoY.
Agchem exports saw a growth of approximately 2% with volume growth of 5%. The performance of new products was a key contributor, with revenue from new products growing by around 40% YoY. Pharma exports contributed approximately 4% of the overall exports.
The firm’s increase in overheads was attributed to promotion expenses for the launch of new products, as well as adding resources to build the Pharma2 business and integrate PHC.
EBITDA redused by 8% to Rs 512.2 crore in Q3 of FY25 from Rs 555 crore in the same quarter last year. EBITDA margin reduced to 27% in Q3 FY25 as against 29% recorded in Q3 FY24.
Gross margin declined to 53% in Q3 FY25, down from 54% in Q3 FY24, a reduction of approximately 85 bps YoY.
On a nine-month basis, the company’s consolidated net profit advanced 1.35% to Rs 1,329.7 crore on a 4.49% rise in revenue from operations to Rs 6,190.7 crore in 9M FY25 over 9M FY24.
PI Industries operates in the domestic agricultural inputs and custom synthesis manufacturing (CSM) exports segments. It is a leading player in the domestic agricultural inputs sector, primarily dealing in agrochemicals and plant nutrients.
Powered by Capital Market - Live News
-
P I Industries consolidated net profit declines 16.92% in the December 2024 quarter
07 - Feb - 2025 12:00 | 83 days ago
Net profit of P I Industries declined 16.92% to Rs 372.70 crore in the quarter ended December 2024 as against Rs 448.60 crore during the previous quarter ended December 2023. Sales rose 0.17% to Rs 1900.80 crore in the quarter ended December 2024 as against Rs 1897.50 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 1900.80 1897.50 0 OPM % 26.94 29.18 - PBDT 579.80 604.10 -4 PBT 480.70 525.80 -9 NP 372.70 448.60 -17 Powered by Capital Market - Live News
-
PI Industries announced that the Board of Directors of the Company at its meeting held on 6 February 2025, inter alia, have recommended the interim dividend of Rs 6 per equity Share (i.e. 600%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
-
PI Industries announces board meeting date
97 days ago
-
However, revenue from operations grew marginally by 0.17% YoY to Rs 1,900.8 crore in the quarter ended 31 December 2024.
Domestic revenues grew by 5% YoY, with volume up by approximately 7%. Biological products’ drove growth, with revenue increasing by 20% YoY.
Agchem exports saw a growth of approximately 2% with volume growth of 5%. The performance of new products was a key contributor, with revenue from new products growing by around 40% YoY. Pharma exports contributed approximately 4% of the overall exports.
The firm’s increase in overheads was attributed to promotion expenses for the launch of new products, as well as adding resources to build the Pharma2 business and integrate PHC.
EBITDA redused by 8% to Rs 512.2 crore in Q3 of FY25 from Rs 555 crore in the same quarter last year. EBITDA margin reduced to 27% in Q3 FY25 as against 29% recorded in Q3 FY24.
Gross margin declined to 53% in Q3 FY25, down from 54% in Q3 FY24, a reduction of approximately 85 bps YoY.
On a nine-month basis, the company’s consolidated net profit advanced 1.35% to Rs 1,329.7 crore on a 4.49% rise in revenue from operations to Rs 6,190.7 crore in 9M FY25 over 9M FY24.
PI Industries operates in the domestic agricultural inputs and custom synthesis manufacturing (CSM) exports segments. It is a leading player in the domestic agricultural inputs sector, primarily dealing in agrochemicals and plant nutrients.
Powered by Capital Market - Live News
-
P I Industries consolidated net profit declines 16.92% in the December 2024 quarter
07 - Feb - 2025 12:00 | 83 days ago
Net profit of P I Industries declined 16.92% to Rs 372.70 crore in the quarter ended December 2024 as against Rs 448.60 crore during the previous quarter ended December 2023. Sales rose 0.17% to Rs 1900.80 crore in the quarter ended December 2024 as against Rs 1897.50 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 1900.80 1897.50 0 OPM % 26.94 29.18 - PBDT 579.80 604.10 -4 PBT 480.70 525.80 -9 NP 372.70 448.60 -17 Powered by Capital Market - Live News
-
PI Industries announced that the Board of Directors of the Company at its meeting held on 6 February 2025, inter alia, have recommended the interim dividend of Rs 6 per equity Share (i.e. 600%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
-
P I Industries consolidated net profit declines 16.92% in the December 2024 quarter
07 - Feb - 2025 12:00 | 83 days ago
Net profit of P I Industries declined 16.92% to Rs 372.70 crore in the quarter ended December 2024 as against Rs 448.60 crore during the previous quarter ended December 2023. Sales rose 0.17% to Rs 1900.80 crore in the quarter ended December 2024 as against Rs 1897.50 crore during the previous quarter ended December 2023.
Particulars Quarter Ended Dec. 2024 Dec. 2023 % Var. Sales 1900.80 1897.50 0 OPM % 26.94 29.18 - PBDT 579.80 604.10 -4 PBT 480.70 525.80 -9 NP 372.70 448.60 -17 Powered by Capital Market - Live News
-
PI Industries announced that the Board of Directors of the Company at its meeting held on 6 February 2025, inter alia, have recommended the interim dividend of Rs 6 per equity Share (i.e. 600%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
-
PI Industries announces board meeting date
97 days ago
Stock Trivia
MF shareholding in P I Industries Ltd has increased by 5.29% since past 3 Months
MF shareholding in P I Industries Ltd has increased by 12.84% since past 1 Year
MF shareholding in P I Industries Ltd has increased by 5.29% since past 3 Months
GovT shareholding in P I Industries Ltd has increased by 200% since past 3 Months
FII shareholding in P I Industries Ltd has decreased by -10.91% since past 1 Year
MF shareholding in P I Industries Ltd has increased by 12.84% since past 1 Year
MF shareholding in P I Industries Ltd has increased by 5.29% since past 3 Months
MF shareholding in P I Industries Ltd has increased by 12.84% since past 1 Year
